Eileen O'Reilly, M.D.
- Assistant Professor of MedicineCornell University Medical CollegeAssociate Faculty MemberMemorial Sloan-Kettering Cancer Center
- Education
M.D., University of Dublin Trinity College School of Medicine, Dublin, Ireland, 1990
- Residency
Internal Medicine, Saint Vincent's Hospital, Dublin, Ireland
- Fellowship
Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York
- Certifications
Internal Medicine (Ireland)
- Hospital Affiliations/Admitting Privileges
Memorial Sloan-Kettering Cancer Center
NewYork-Presbyterian Hospital
Dr. O’Reilly is a leading authority in the clinical study and treatment of pancreatic cancer at Memorial Sloan-Kettering Cancer Center where she is a member of the Gastrointestinal Oncology Service. Her expertise includes esophageal cancer, gastric cancer, pancreatic, hepatobiliary, colorectal cancers, and unknown primary tumors. Dr. O'Reilly's primary clinical interests include the development of new treatment and therapies against pancreatic cancer. She is currently the principal investigator for six clinical trials, testing treatments against resectable and unresectable pancreatic cancer. She has published over 30 articles in peer-reviewed journals including Gastrointestinal Cancer Research, Pancreatology, and Cancer Gene Therapy. Dr. O'Reilly also co-authored the book "100 Questions and Answers About Pancreatic Cancer." Dr. O'Reilly was recognized among Castle Connolly's 'America's Top Doctors' from 2006 to 2009 and 'America's Top Doctors for Cancer' from 2005 to 2007.
As an assistant professor of medicine at Cornell University Medical College, Dr. O'Reilly is active in instructing medical students and residents in medical oncology. She has lectured at national conferences for pancreatic and gastrointestinal cancer. She was also an invited speaker at the World Congress on Gastrointestinal Cancer held in Spain in the summer of 2009. Dr. O'Reilly serves on several committees at Memorial Sloan-Kettering Cancer Center including being involved in their Institutional Review Board and Research and Clinical Council Committee. Dr. O'Reilly serves on the Science Board for the Lorenzen Cancer Foundation and is a member of the American Society of Clinical Oncology.
